154 related articles for article (PubMed ID: 28634077)
1. DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.
Huang L; Chen K; Cai ZP; Chen FC; Shen HY; Zhao WH; Yang SJ; Chen XB; Tang GX; Lin X
Biochem Biophys Res Commun; 2017 Aug; 490(3):707-712. PubMed ID: 28634077
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
[TBL] [Abstract][Full Text] [Related]
3. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
[TBL] [Abstract][Full Text] [Related]
4. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
[No Abstract] [Full Text] [Related]
5. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
Qu D; Cui F; Lu D; Yang Y; Xu Y
Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
[TBL] [Abstract][Full Text] [Related]
6. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
7. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
9. DEPDC1 upregulation promotes cell proliferation and predicts poor prognosis in patients with gastric cancer.
Gong Z; Chu H; Chen J; Jiang L; Gong B; Zhu P; Zhang C; Wang Z; Zhang W; Wang J; Li C; Zhao H
Cancer Biomark; 2021; 30(3):299-307. PubMed ID: 33361586
[TBL] [Abstract][Full Text] [Related]
10. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
Kanehira M; Harada Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
Oncogene; 2007 Sep; 26(44):6448-55. PubMed ID: 17452976
[TBL] [Abstract][Full Text] [Related]
11. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
Shen J; Xi M
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
[TBL] [Abstract][Full Text] [Related]
12. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.
Harada Y; Kanehira M; Fujisawa Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
Cancer Res; 2010 Jul; 70(14):5829-39. PubMed ID: 20587513
[TBL] [Abstract][Full Text] [Related]
13. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
14. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis.
Chen D; Ito S; Hyodo T; Asano-Inami E; Yuan H; Senga T
Exp Cell Res; 2017 Sep; 358(2):101-110. PubMed ID: 28602627
[TBL] [Abstract][Full Text] [Related]
16. DEPDC1 as a crucial factor in the progression of human osteosarcoma.
Shen L; Li H; Liu R; Zhou C; Bretches M; Gong X; Lu L; Zhang Y; Zhao K; Ning B; Yang SY; Zhang A
Cancer Med; 2023 Mar; 12(5):5798-5808. PubMed ID: 36479633
[TBL] [Abstract][Full Text] [Related]
17. DEPDC1 up-regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells.
Wang W; Li A; Han X; Wang Q; Guo J; Wu Y; Wang C; Huang G
J Cell Mol Med; 2020 Nov; 24(22):13303-13313. PubMed ID: 33021072
[TBL] [Abstract][Full Text] [Related]
18. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
20. Silencing eL31 suppresses the progression of colorectal cancer via targeting DEPDC1.
Sharen G; Li X; Sun J; Zhang L; Xi W; Zhao X; Han F; Jia L; A R; Cheng H; Hou M
J Transl Med; 2022 Oct; 20(1):493. PubMed ID: 36309731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]